Expert Commentary: Practice-Changing Advances in Type 2 Diabetes

Learn expert perspectives on pivotal studies of SGLT2 inhibitors in type 2 diabetes including possible renal protection in those with or without established chronic kidney disease.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Merck